Getting to know JAK

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Neoplastic clone dominance is key to disease progression. In this issue of Blood, Fleischman et al. suggest that in myeloproliferative neoplasms (MPNs), neoplastic clone dominance is linked to JAK2 V617F effects on responsiveness to and production of tumor necrosis factor (TNF)-α.

Original languageEnglish
Pages (from-to)6235-6237
Number of pages3
JournalBlood
Volume118
Issue number24
DOIs
StatePublished - Dec 8 2011

Fingerprint

Blood
Clone Cells
Tumor Necrosis Factor-alpha
Disease Progression
Neoplasms

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Getting to know JAK. / Broxmeyer, Hal.

In: Blood, Vol. 118, No. 24, 08.12.2011, p. 6235-6237.

Research output: Contribution to journalArticle

Broxmeyer, Hal. / Getting to know JAK. In: Blood. 2011 ; Vol. 118, No. 24. pp. 6235-6237.
@article{02461ac55b4c4f8e82473edd5135154c,
title = "Getting to know JAK",
abstract = "Neoplastic clone dominance is key to disease progression. In this issue of Blood, Fleischman et al. suggest that in myeloproliferative neoplasms (MPNs), neoplastic clone dominance is linked to JAK2 V617F effects on responsiveness to and production of tumor necrosis factor (TNF)-α.",
author = "Hal Broxmeyer",
year = "2011",
month = "12",
day = "8",
doi = "10.1182/blood-2011-09-377291",
language = "English",
volume = "118",
pages = "6235--6237",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "24",

}

TY - JOUR

T1 - Getting to know JAK

AU - Broxmeyer, Hal

PY - 2011/12/8

Y1 - 2011/12/8

N2 - Neoplastic clone dominance is key to disease progression. In this issue of Blood, Fleischman et al. suggest that in myeloproliferative neoplasms (MPNs), neoplastic clone dominance is linked to JAK2 V617F effects on responsiveness to and production of tumor necrosis factor (TNF)-α.

AB - Neoplastic clone dominance is key to disease progression. In this issue of Blood, Fleischman et al. suggest that in myeloproliferative neoplasms (MPNs), neoplastic clone dominance is linked to JAK2 V617F effects on responsiveness to and production of tumor necrosis factor (TNF)-α.

UR - http://www.scopus.com/inward/record.url?scp=83455220282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83455220282&partnerID=8YFLogxK

U2 - 10.1182/blood-2011-09-377291

DO - 10.1182/blood-2011-09-377291

M3 - Article

C2 - 22161849

AN - SCOPUS:83455220282

VL - 118

SP - 6235

EP - 6237

JO - Blood

JF - Blood

SN - 0006-4971

IS - 24

ER -